EMA – Development of a guideline on the quality aspects of mRNA vaccines - Scientific guideline
Year: 2025
Type: other
Abstract: The EMA is currently developing a guideline on the quality aspects of mRNA vaccines and recently published a draft version of the guideline for consultation until 30 September 2025. It addresses specific aspects regarding the manufacturing process, characterisation, specifications and analytical control of mRNA vaccines, as well as the definition of starting materials, active substance and finished product for mRNA vaccines. Additional regulatory considerations are provided for changes in ex...
DOI: 10.58079/13xyg
Author: Vroby
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6973897662
Cites:
Cited by:
Related to:
